Predicting Lympho-Vascular Space Invasion in Endometrial Cancers with Mucinous Carcinomatous Components |
Ilker, Selcuk
(Gynecologic Oncology Unit, Zekai Tahir Burak Women's Health, Education and Research Hospital)
Nilufer, Cetinkaya (Gynecologic Oncology Unit, Zekai Tahir Burak Women's Health, Education and Research Hospital) Firat, Cuylan Zeliha (Gynecologic Oncology Unit, Zekai Tahir Burak Women's Health, Education and Research Hospital) Bulent, Ozdal (Gynecologic Oncology Unit, Zekai Tahir Burak Women's Health, Education and Research Hospital) Hatice, Bayramoglu (Pathology Unit, Zekai Tahir Burak Women's Health, Education and Research Hospital) Tayfun, Gungor (Department of Obstetrics and Gynecology, Hitit University, Faculty of Medicine) |
1 | Ayeni TA, Bakkum-Gamez JN, Mariani A, et al (2013). Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas. Gynecol Oncol, 129, 478-85. DOI |
2 | Binesh F, Akhavan A, Behniafard N, et al (2014). Endometrial adenocarcinoma: clinicopathologic and survival characteristics in Yazd, Iran. Asian Pac J Cancer Prev, 15, 2797-801. DOI ScienceOn |
3 | Cetinkaya K, Atalay F, Bacinoglu A (2014). Risk factors of lymph node metastases with endometrial carcinoma. Asian Pac J Cancer Prev, 15, 6353-6. DOI |
4 | Chung HH, Kim JW, Park NH, et al (2006). Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer. Acta Obstet Gynecol Scand, 85, 1501-5. DOI |
5 | Creasman WT, Morrow CP, Bundy BN, et al (1987). Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer, 60, 2035-41. DOI |
6 | Ebina Y, Sakuragi N, Hareyama H, et al (2002). Para-aortic lymph node metastasis in relation to serum CA 125 levels and nuclear grade in endometrial carcinoma. Acta Obstet Gynecol Scand, 81, 458-65. DOI |
7 | Felix AS, Weissfeld JL, Stone RA, et al (2010). Factors associated with Type I and Type II endometrial cancer. Cancer Causes Control, 21, 1851-6. DOI |
8 | Gungor T, Kanat-Pektas M, Ustunyurt E, et al (2009). Synchronous primary tumors of the female genital tract: a single center experience. Arch Gynecol Obstet, 279, 667-72. DOI |
9 | Guntupalli SR, Zighelboim I, Kizer NT, et al (2012). Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer. Gynecol Oncol, 124, 31-5. DOI |
10 | Jalloul RJ, Elshaikh MA, Ali-Fehmi R, et al (2012). Mucinous adenocarcinoma of the endometrium: case series and review of the literature. Int J Gynecol Cancer, 22, 812-8. DOI |
11 | Kelly PJ, Archbold P, Price JH, et al (2010). Serum CA19.9 levels are commonly elevated in primary ovarian mucinous tumours but cannot be used to predict the histological subtype. J Clin Pathol, 63, 169-73. DOI |
12 | Larson DM, Connor GP, Broste SK, et al (1996). Prognostic significance of gross myometrial invasion with endometrial cancer. Obstet Gynecol, 88, 394-8. DOI |
13 | Mariani A, El-Nashar SA, Dowdy SC (2010). Lymphadenectomy in endometrial cancer: which is the right question? Int J Gynecol Cancer, 20, S52-4. DOI |
14 | Mariani A, Webb MJ, Keeney GL, et al (2001). Role of wide/ radical hysterectomy and pelvic lymph node dissection in endometrial cancer with cervical involvement. Gynecol Oncol, 83, 72-80. DOI |
15 | Melhem MF, Tobon H (1987). Mucinous adenocarcinoma of the endometrium: a clinico-pathological review of 18 cases. Int J Gynecol Pathol, 6, 347-55. DOI |
16 | Morrow CP, Bundy BN, Kurman RJ, et al (1991). Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a gynecologic oncology group study. Gynecol Oncol, 40, 55-65. DOI |
17 | Musa F, Huang M, Adams B, et al (2012). Mucinous histology is a risk factor for nodal metastases in endometrial cancer. Gynecol Oncol, 125, 541-5. DOI |
18 | Natee J, Kietpeerakool C, Srisomboon J, et al (2006). Clinicopathologic analysis of women with synchronous primary carcinomas of the endometrium and ovary: 10- year experience from Chiang Mai university hospital. Asian Pac J Cancer Prev, 7, 234-8. |
19 | Rauh-Hain JA, Vargas RJ, Clemmer J, et al (2014). Mucinous Adenocarcinoma of the Endometrium Compared With Endometrioid Endometrial Cancer: A SEER Analysis. Am J Clin Oncol. [Epub ahead of print]. |
20 | Patsavas K, Woessner J, Gielda B, et al (2011). Optimal surgical debulking in uterine papillary serous carcinoma affects survival. Gynecol Oncol, 121, 581-5. DOI |
21 | Sanjuan A, Cobo T, Pahisa J, et al (2006). Preoperative and intraoperative assessment of myometrial invasion and histologic grade in endometrial cancer: role of magnetic resonance imaging and frozen section. Int J Gynecol Cancer, 16, 385-90. DOI |
22 | Schink JC, Lurain JR, Wallemark CB, et al (1987). Tumor size in endometrial cancer: a prognostic factor for lymph node metastasis. Obstet Gynecol, 70, 216-9. |
23 | Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30. DOI ScienceOn |
24 | Taskiran C, Yuce K, Geyik PO, et al (2006). Predictability of retroperitoneal lymph node metastasis by using clinicopathologic variables in surgically staged endometrial cancer. Int J Gynecol Cancer, 16, 1342-7. DOI |
25 | Vaizoglu F, Yuce K, Salman MC, et al (2013). Lymphovascular space involvement is the sole independent predictor of lymph node metastasis in clinical early stage endometrial cancer. Arch Gynecol Obstet, 288, 1391-7. DOI |
26 | Wilairat W, Benjapibal M (2012). Presence of anemia and poor prognostic factors in patients with endometrial carcinoma. Asian Pac J Cancer Prev, 13, 3187-90. DOI ScienceOn |
![]() |